Chlorzoxazone is a centrally acting benzoxazolone skeletal muscle relaxant used for acute musculoskeletal pain and spasm, and also widely employed as a selective CYP2E1 probe substrate in in vitro drug metabolism studies. Simson Pharma's Chlorzoxazone reference standard and impurities support both therapeutic QC and pharmacokinetic-research applications.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Chlorzoxazone Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
